Electromed (NYSE:ELMD) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPS

Electromed (NYSE:ELMD) announced its earnings results on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13, Zacks reports. The business had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a return on equity of 15.32%.

Electromed Trading Down 0.4 %

ELMD stock traded down $0.12 during trading on Friday, hitting $28.77. The company had a trading volume of 48,957 shares, compared to its average volume of 41,550. The company has a fifty day moving average price of $21.67 and a two-hundred day moving average price of $17.65. Electromed has a fifty-two week low of $9.81 and a fifty-two week high of $30.00. The company has a market cap of $243.39 million, a P/E ratio of 40.11 and a beta of 0.27.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.